# Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

> **NCT04328337** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 40 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Intralipid, 20% Intravenous Emulsion
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04328337
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-08
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04328337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04328337, "Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism". Retrieved via MORVS 2026-10-05 from https://api.morvs.ai/clinical/NCT04328337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*